Company Overview
Snapshot
Founded in March 2020 by Menny Sherman and Eilon Sherman, Sherman Diagnostics operates with 1–10 employees. The company has secured funding across two rounds, with Sanara Ventures participating as an investor in both rounds. In May 2024, Sanara Ventures made a follow-on investment in the company.
Business overview
Sherman Diagnostics is a Health Tech & Life Sciences company focused on developing diagnostic technology for pathogen detection. The company's core product is a diagnostic platform capable of detecting DNA/RNA-based pathogens from any biological sample, enabling rapid, economical, and efficient testing for infectious diseases like coronavirus. Sherman Diagnostics serves the healthcare industry, including laboratories and patients, and operates within the medical devices sector, specifically diagnostics devices and medical equipment.
Log in to access full profile ›Company Intelligence Q&A
- When was Sherman Diagnostics founded and by whom?
- Sherman Diagnostics was founded in March 2020 by co-founders Menny Sherman and Eilon Sherman.
- What is Sherman Diagnostics' primary focus in the healthcare sector?
- Sherman Diagnostics focuses on developing diagnostic technology for detecting pathogens using any biological sample, aiming for rapid, economical, and efficient testing of infectious diseases.
- Which investor participated in Sherman Diagnostics' funding rounds?
- Sanara Ventures participated as an investor in Sherman Diagnostics' funding rounds in October 2020 and May 2024.
- What type of technology does Sherman Diagnostics offer?
- Sherman Diagnostics offers diagnostic technology designed to detect DNA/RNA-based pathogens, applicable for rapid testing of infectious diseases.
- In which sector does Sherman Diagnostics primarily operate?
- Sherman Diagnostics operates primarily in the Health Tech & Life Sciences sector, specifically within Medical Devices and Diagnostics Devices.